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Abstract
Oral mucositis (OM) is a common and costly complication of chemotherapy cancer treatment
resulting in high costs and poor outcomes and experiences for chemotherapy patients. At the site
of this quality improvement (QI) project, the quality and content of the oral care patient
education for chemotherapy patients is inconsistent. The aim of this project was to improve oral
care completion and knowledge by 20% among inpatient chemotherapy patients and in turn
reduce incidence of chemotherapy-induced OM. A pre-intervention survey was distributed to
eight eligible patients to assess baseline oral care completion and knowledge. Patients were
provided with an oral care education session consisting of written and verbal education and their
oral care completion and knowledge was reassessed in a post-intervention survey 24-30 hours
later. The specific aims of the project were partially achieved. Oral care completion improved by
28% for toothbrushing and by 12% for oral rinsing. Additionally, oral care knowledge improved
by 28% for OM understanding and by 12% for understanding the impact of oral care on one’s
health. While these improvements did not fully achieve the specific aims, the improvement seen
across all survey statements demonstrates the importance and effectiveness of the intervention.
This project highlights the role of the Clinical Nurse Leader (CNL) as an educator, client
advocate, and lifelong learner.
Keywords: chemotherapy-induced oral mucositis, oral care, quality improvement
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Introduction
Problem Description
Oral mucositis (OM) is a common, costly, and serious complication of chemotherapy
cancer treatment. Chemotherapy treatment breaks down rapidly dividing cells, including the
epithelial cells of the mucosa, creating erythema, edema, atrophy, and/or ulceration of the oral
mucosa (The Oral Cancer Foundation, 2022). The World Health Organization grades the severity
of OM with the following 0-4 Oral Toxicity Scale:
Grade 0: None, Grade I: Mild OM with oral soreness and erythema, Grade II: Moderate
OM with oral erythema and ulcers, patient can swallow solid food, Grade III: Severe OM
with ulcers and extensive erythema, patient cannot swallow solid food, and Grade IV:
Life-threatening OM, oral alimentation not possible. (Naidu et al., 2004, p. 425)
A multitude of factors contribute to the severity of OM including the patient’s level of
immunosuppression, genetic predisposition, local tissue damage, and the local oral environment
(Treister, 2017). The inflammation of the mouth can result in pain, infection, inability to eat, and
weight loss. Severe OM can cause interruptions and dose reductions in chemotherapy treatment,
leading to poorer patient outcomes (Brown & Gupta, 2020). For patients undergoing
chemotherapy prior to bone marrow transplantation (BMT), OM has been described as the “most
debilitating aspect of their treatment,” demonstrating the grave impact it can have on patients’
cancer experiences and treatment progression (Treister, 2017, p. 2).
OM affects approximately 40% of chemotherapy patients and up to 85% of patients
undergoing chemotherapy prior to BMT (Pulito et al., 2020). It can contribute to longer hospital
admissions and increased cost of care. The cost of care can be further exacerbated by a need for
parenteral nutrition, antibiotics, pain medications, and medicated rinses and can contribute to
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additional costs of $3,700 per cycle of chemotherapy treatment and upwards of $70,000 for
chemotherapy with BMT (Treister, 2017; Elting & Chang, 2019). Collectively, poor patient
outcomes and experiences as well as high accrued costs associated with chemotherapy-induced
OM highlight the need for change. Patient education focused on the importance of good oral care
throughout chemotherapy treatment is essential as evidence suggests that regular prophylactic
oral care can mitigate the risk of mucositis to a degree (Brown & Gupta, 2020).
Local Problem
At the site of this QI project, the quality and content of the oral care patient education for
chemotherapy patients is inconsistent. There is an oral care policy in place for BMT patients,
however not for chemotherapy patients, resulting in a lack of consistent oral care completion
among chemotherapy patients. The oral care policy defines regular oral care as toothbrushing
twice daily and oral rinsing four times daily, after each meal and before bed (DartmouthHitchcock, 2021). The project leader performed a tick and tally to assess current oral care
completion (N=9), 55.6% of the surveyed patients completed regular oral care and 44.4% did
not, highlighting a need for improvement. Additionally, a previous QI project conducted by the
Clinical Nurse Leader (CNL) examined the actual versus projected length of hospital stay for 11
patients with chemotherapy-induced OM. The CNL found that the mean actual hospital stay was
11.4 days longer than the projected stay which contributes to higher costs (Pomeroy, 2021). The
CNL also found that there was wide variation in staff oral care documentation, with oral care
documentation rates ranging from 25%-63% over an eight-week period of chart audits (Pomeroy,
2021). The microsystem assumes that if oral care is not being documented, it is not being
completed. Collectively, this data highlights the need for a patient education intervention to
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improve oral care completion and knowledge and in turn reduce incidence of OM among
chemotherapy patients.
Available Knowledge
PICO
The following PICO question was developed: In adult oncology patients receiving
chemotherapy, how does daily oral care compared to no intervention affect incidence of
chemotherapy-induced OM?
Critical Appraisal of the Evidence
Hong et al. (2019) conducted a systematic review to examine the effects of basic oral care
on preventing and managing OM secondary to cancer therapy. The findings of the review were
used to update the basic oral care recommendations in the Multinational Association of
Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) Clinical
Practice Guidelines (Hong et al., 2019). Relevant papers from 2011 to 2016 were identified in
PubMed and Web of Science and ultimately 17 new articles were included in the review. Two
independent reviewers and a standard electronic form were used to identify and extract data. The
articles examined six interventions of basic oral care including “professional oral care, multiagent combination oral care, patient education, saline, sodium bicarbonate, and chlorhexidine”
(Hong et al., 2019, p. 3951). Eight of the included studies were randomized controlled trials
(RCTs) examining the following four interventions, “professional oral care, multi-agent
combination oral care, patient education, and chlorhexidine” (Hong et al., 2019, p. 3951). Each
intervention was given a guideline determination of “recommendation, suggestion, or no
guideline possible” based on the level of evidence of the studies (Hong et al., 2019, p. 3951).
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Hong et al. (2019) reviewed three RCTs and six comparative studies examining the role
of professional oral care in preventing OM. Two RCTs found reduced OM severity and one RCT
found decreased associated pain, however variation in patient demographics and treatment
methods resulted in insufficient evidence to support this intervention and “no guideline was
possible” (Hong et al., 2019, p. 3952). Five RCTs examined the effects of multi-agent
combination oral care protocols on OM prevention. The panel suggested that “the
implementation of multi-agent combination oral care protocols is beneficial for the prevention of
OM during chemotherapy and hematopoietic stem cell transplantation” (Hong et al., 2019, p.
3955). One RCT and two comparative studies examined the effects of patient education. Due to
insufficient and conflicting data, “no guideline was possible regarding the use of patient
education for the prevention of OM” (Hong et al., 2019, p. 3962). However, an expert opinion
stating that patient education is beneficial in improving patients’ “self-management and
adherence to the recommended oral care treatment” complemented the guideline (Hong et al.,
2019, p. 3962) Two RCTs examined the use of saline and two RCTs examined the use of sodium
bicarbonate. No guideline was possible due to insufficient data, however the expert opinion that
saline and sodium bicarbonate rinses promote oral health and improve patient comfort
complemented the guideline. Five RCTs examining the impact of chlorhexidine were reviewed.
The panel stated that “no guideline was possible with regard to the use of chlorhexidine in the
prevention of OM” as a result of inconsistent data (Hong et al., 2019, p. 3963). Collectively, the
work of Hong et al. (2019) encourages the use of multi-agent combination oral care protocols,
bland rinses, and patient education for the prevention and treatment of OM. The authors
acknowledge that there is “limited evidence from high-quality, rigorous studies” (Hong et al.,
2019, p. 3963). Future RCTs with large sample sizes and greater consistency between cancer

IMPLEMENTING A PATIENT-CENTERED EDUCATION INTERVENTION TO REDUCE INCIDENCE
OF OM AMONG INPATIENT CHEMOTHERAPY PATIENTS

8

treatment methods are needed. Additionally, the review includes both randomized and nonrandomized studies, the use of non-randomized studies weakens the overall quality of the
findings. Strengths of the review include the use of independent reviewers as well as the
Somerfield and Hadorn criteria to eliminate bias and evaluate study quality. The findings of
Hong et al. (2019) support the use of oral care in cancer patients.
Yu et al. (2020) conducted a network meta-analysis of RCTs examining the effects of
nine oral care solutions on the prevention of OM among cancer patients. Authors searched
PubMed, Embase, Scopus, the Cochrane Library, and Google Scholar to identify 28 RCTs
involving 1861 patients to include in the analysis. Nine oral care solutions including
chlorhexidine, benzydamine, sucralfate, povidone-iodine, granulocyte macrophage colony
stimulating factor (GM-GSF), honey, allopurinol, and curcumin were investigated. The Cochrane
Handbook was used to evaluate the RCT quality and the nine interventions were ranked
according to the Surface Under the Cumulative Ranking curve (SUCRA). The SUCRA
probabilities of various oral solutions on preventing OM showed the following rank of efficacy:
curcumin (6.4), honey (23.9), benzydamine (29.2), chlorhexidine (42.3), allopurinol (48.6),
sucralfate (56.4), GM-GSF (61.2), povidone-iodine (71.2), aloe (74.6), and placebo (84.8) (Yu et
al., 2020). The statistical analysis of Yu et al. (2020) found that chlorhexidine (RR= 0.39; 95%
CI, 0.81-0.82), benzydamine (RR= 0.30; 95% CI, 0.13-0.68), honey (RR= 0.25; 95% CI, 0.110.56) and curcumin (RR= 0.08; 95% CI, 0.01-0.60) were more effective than placebo in
preventing OM (p< 0.05) (Yu et al., 2020). The authors also found that honey (RR= 0.32; 95%
CI, 0.11-0.97) and curcumin (RR= 0.10; 95% CI, 0.02-0.60) were more effective than povidoneiodine (p< 0.05) (Yu et al., 2020). The comparisons for the other oral care interventions were not
statistically significant.
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These findings suggest that various oral care solutions, specifically curcumin and honey,
are effective at preventing OM in cancer patients, however several limitations must be
acknowledged. Many of the studies included in the analysis had small sample sizes which limits
the generalizability of the findings. Additionally, two of the authors participated in extracting the
chosen articles which contributes to bias and can impact the validity of the findings. Strengths
include use of RCTs and the Cochrane Handbook to assess quality of each study. The findings of
Yu et al. (2020) highlight the importance of oral care solutions in preventing OM among cancer
patients.
Salvador et al. (2012) conducted a pilot RCT to examine the effects of an oral
intervention on the incidence and severity of OM in autologous stem cell transplant (ASCT)
patients with multiple myeloma. Participants were randomly assigned to the experimental group
(n= 23) or the control group (n= 23). All participants received education on basic oral hygiene
and participated in oral self-care skills training. They all received their own cryopreserved stem
cells on Day 0 and high-dose melphalan chemotherapy on Day 1. The participants in the control
group continued with their usual care which included toothbrushing, sodium bicarbonate
mouthwash, lip moisturizer, and flossing (if platelets were greater than 50,000). In addition to the
standard oral care, participants in the experimental group sucked on ice chips for five minutes
before the melphalan infusion, during the entire infusion, and for 30 mins after the administration
of the melphalan chemotherapy. The primary outcomes were incidence and severity of OM
(determined by the World Health Organization Oral Toxicity Scale) and the secondary outcomes
were mucositis-related pain, functional intake of food and fluids, and length of hospital stay. A
visual analogue scale (ranging from 0-10) was used to assess pain as was the amount of opioid
analgesics documented for pain control. Data was collected on days 1, 3, 6, 9, and 12. The
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results showed that all participants were symptom free on days 1 and 3. However, signs and
symptoms of OM were present on day 6 and there were significant differences in mucositis
severity scores between the experimental and control groups on days 6 (0.09 vs. 0.05, F= 5.85,
p< 0.02), 9 (0.43 vs. 1.14, F= 16.86, p< 0.001), and 12 (0.04 vs. 0.41, F= 4.58, p< 0.03)
(Salvador et al., 2012). Additionally, the mean mucositis-related pain score was significantly less
in the experimental group (0.3 ± 0.23) compared to the control group (1.64 ± 0.24) (p<0.001) as
was the mean milligrams of Morphine IV equivalent pain medications (34mg in the experimental
group vs. 54mg in the control group) (p<0.001) (Salvador et al., 2012). The experimental group
had a shorter length of hospital stay (14.1 ± 2.8 days) compared to the control group (15.3 ± 2.8
days), however the difference was not statistically significant (p= 0.17) (Salvador et al., 2012).
Similarly, there was no significant difference between study groups on functional intake of foods
and fluids.
While the findings of Salvador et al. (2012) did not prevent OM, the oral cryotherapy
intervention did significantly reduce OM severity and OM-associated pain among multiple
myeloma ASCT patients. However, when assessing the quality of this data, it is important to note
that there were significant differences in age (p = 0.02) and education (p= 0.05) between the two
groups, with a higher mean age and education in the experiment group which contributes to
participation bias. However, the use of randomization strengthens the quality of the findings.
Overall, the findings of Salvador et al. (2012) highlight the benefit of oral care interventions in
decreasing the severity and pain of OM.
Saito et al. (2014) conducted a RCT to examine the effects of prophylactic professional
oral health care (POHC) on the prevention of chemotherapy-induced OM. In this study, POHC
was performed by either dentists or dental hygienists. 26 breast cancer patients, undergoing

IMPLEMENTING A PATIENT-CENTERED EDUCATION INTERVENTION TO REDUCE INCIDENCE
OF OM AMONG INPATIENT CHEMOTHERAPY PATIENTS

11

adjuvant chemotherapy, participated in the study. Patients were randomly assigned to the selfcare control group or the POHC experimental group. Both groups received education on
brushing, nutrition, and lifestyle, however the POHC group received weekly scaling and
brushing by a dentist or dental hygienist. Examined outcomes included the oral environment
measured by the Eilers’ Oral Assessment Guide (OAG) and the OM severity according to the
National Cancer Institute Common Terminology Criteria for Adverse Events. In the POHC
group, “the OAG score was either improved or unchanged in 11” of the 14 patients (Saito et al.,
2014, p. 2938). In the self-care group, five patients had improved or unchanged scores and nine
patients had deteriorated scores after their chemotherapy treatment. There was significantly less
deterioration in the oral assessment in the POHC group compared to the self-care group (p=
0.01) (Saito et al., 2014). Additionally, there was a significantly higher incidence of OM in the
self-care group compared to the POHC group (p= 0.04) (Saito et al., 2014).
The findings of Saito et al. (2014) suggest that POHC performed throughout
chemotherapy treatment can prevent degradation of the oral mucosa and reduce incidence and
severity of OM among breast cancer patients. The two groups were statistically similar in regards
to age, body mass index, and number of teeth which strengthens causality. However, the
comparability at baseline and small sample sizes in this study limit generalizability beyond this
population of female breast cancer patients. Additionally, randomization contributes to the
strength of the overall findings. The work of Saito et al. (2014) highlights the efficacy of POHC
in chemotherapy patients.
Evidence Synthesis
The evidence suggests that various oral care interventions are effective at preventing and
reducing severity of chemotherapy-induced OM. The aforementioned four studies all found a

IMPLEMENTING A PATIENT-CENTERED EDUCATION INTERVENTION TO REDUCE INCIDENCE
OF OM AMONG INPATIENT CHEMOTHERAPY PATIENTS

12

reduction in incidence and severity of chemotherapy-induced OM after oral care interventions.
Systematic reviews and meta-analyses of RCTs are the gold standard to summate available
evidence regarding a clinical question. This investigation included a systematic review/clinical
practice guideline (level 1), a meta-analysis (level 1), and two randomized-controlled trials (level
2). Despite the high-quality evidence supporting the use of oral care interventions to prevent and
reduce severity of chemotherapy-induced OM, it is essential to have a strong understanding of
the type of study, the level of evidence, and the resulting limitations that hinder the validity of
the findings. Future research must prioritize RCTs with large sample sizes which will fuel the
formation of systematic reviews and meta-analyses, further enhancing the quality of available
evidence. More high-quality and extensive research would enable registered nurses and CNLs to
advocate for evidence-based, patient-specific oral care interventions to prevent incidence and
reduce severity of chemotherapy-induced OM.
Implications for this QI Project
With the evidence supporting the use of oral care interventions to prevent and reduce
severity of chemotherapy-induced OM, a QI project aimed at improving the oral care habits of
chemotherapy patients is vital to reducing incidence and severity of OM. The microsystem has
low rates of oral care completion among chemotherapy patients and low rates of oral care
documentation among staff. As the evidence suggests, this nonadherence to daily oral care leaves
a vulnerable population at risk for OM. This QI project could improve patient outcomes and
experiences and motivate nurses on the unit to participate in evidence-based interventions such
as oral care.
Rationale
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The framework for this quality improvement project was the Institute for Healthcare
Improvement’s Plan-Do-Study-Act (PDSA) model. The PDSA model is a four-step scientific
method for testing and carrying out change (Institute for Healthcare Improvement, 2022). With
this model, a change is initially tested on a small scale and modified and refined through
repeated PDSA cycles before being implemented on a larger scale with an entire unit or patient
population (Institute for Healthcare Improvement, 2022).
Plan
In the Plan phase of this QI project, a 5P Assessment was initially conducted to examine
the functionality of the microsystem. The purpose, patients, and processes portions of the
assessment provided insight into the problem of OM and lack of oral care completion among
chemotherapy patients in the microsystem. Insight was gathered from nursing staff and leaders
and the CNL shared previous QI work investigating the role of staff education on oral care
documentation and OM. A fishbone diagram was created to perform a root cause analysis and
oral care completion was identified as a potential focus. A tick and tally (N=9) was performed to
assess the current state of oral care completion among chemotherapy patients in the microsystem.
A literature review was completed and the evidence supported the promotion of regular oral care
to prevent and/or reduce severity of chemotherapy-induced OM. The project leader collaborated
with key stakeholders to construct a patient education intervention. Pre and post-intervention
surveys as well as an educational pamphlet were created by the project leader and approved by
the unit manager and CNL.
Do
During the Do phase, the patient education intervention was carried out. 10 eligible
participants completed a pre-intervention survey assessing their current oral care completion and
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knowledge. The survey was immediately followed by a written and verbal education session with
the project leader. Participants completed a post-intervention survey at least 24 hours after the
education intervention.
Study
In the Study phase, the mean Likert survey scores were compared to assess the efficacy of
the education intervention. A paired t-test was performed to determine if the pre and postintervention scores for oral care completion and knowledge were significantly different.
Act
In the Act phase, the results of this QI project were presented verbally to the staff and
leaders of the microsystem as well as with a poster hung on the unit. The patient education
resources (verbal content and written pamphlets) were provided to the unit and kept in an
accessible location with other staff resources. The staff were encouraged to provide all
chemotherapy patients with oral care education.
Specific Aims
The global aim of this project was to reduce incidence of chemotherapy-induced OM
among chemotherapy patients. The specific aims of the project include the following:
1. Increase oral care completion in chemotherapy patients by 20% by July 1, 2022
2. Improve oral care knowledge in chemotherapy patients by 20% by July 1, 2022
Methods
Context
The microsystem for this QI project was a 33-bed Hematology/Oncology/BMT unit
within a 400-bed academic medical center and level 1 trauma center in New England (DHMC,
2022). The unit primarily provides care to patients with solid tumors, blood malignancies and
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disorders. The microsystem is a part of a comprehensive cancer center which collaborates with
inpatient units like this microsystem to provide cancer care (Dartmouth Cancer Center, 2022). A
5P Microsystem Assessment was conducted to provide a framework for the QI project and the
purpose, patients, and processes portions of the assessment provided relevant information.
Purpose
The microsystem aims to provide “advanced, comprehensive cancer care to patients
within a compassionate environment” (Dartmouth Cancer Center, 2022, para. 1). The mission
statement of the mesosystem, the cancer center, is to “prevent and cure cancer through
pioneering interdisciplinary research, to translate new knowledge into better prevention and
treatment, and to provide effective and compassionate clinical care that improves the lives of
patients with cancer and their families” (Dartmouth Cancer Center, 2022, para 1). Similarly, the
macrosystem strives to “advance health through research, education, clinical practice, and
community partnerships, providing each person the best care, in the right place, at the right time,
every time” (DHMC, 2022, para. 7). Collectively, these statements reflect a commitment to
quality improvement as all levels of care strive to provide high-quality care and improve patient
outcomes and experiences.
Patients
Patients included in this QI project were adult (≥18 years old) oncology/chemotherapy
patients admitted to the microsystem. Common medical conditions for this patient population
include acute myeloid leukemia, acute lymphocytic leukemia, multiple myeloma, and diffuse
large B-cell lymphoma. Chemotherapy breaks down rapidly dividing cells including the mucosal
epithelial cells lining the gastrointestinal tract leaving chemotherapy patients at an increased risk
for developing OM (Treister, 2022).
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Processes
While there is a preventative oral care protocol in place for BMT patients, there are no
oral care policies or oral care education guidelines for patients admitted for chemotherapy
treatment aside from BMT. Patients are informed of the risk of OM during the chemotherapy
informed consent with the provider but are not provided comprehensive education about the
importance of regular oral care. Currently, the quality and content of the oral care patient
education is inconsistent.
Cost-Benefit Analysis
A cost-benefit analysis was conducted to examine the financial implications of the
project. OM can lead to longer hospital admissions and increased cost of care. Previous QI work
by the unit CNL found that the mean actual hospital stay on the unit was 11.4 days longer than
the projected stay for patients that developed chemotherapy-induced OM (Pomeroy, 2021).
Additionally, research shows that OM can contribute to additional costs of $3,700 per
chemotherapy cycle and upwards of $70,000 for patients undergoing chemotherapy and BMT
(Elting & Chang, 2019). Implementing an intervention to improve oral care completion and
knowledge among chemotherapy patients can reduce incidence of OM and reduce hospital costs.
This intervention did not result in any additional costs for the hospital at this time as the project
leader supplied the printed and laminated educational pamphlet. The project leader spent
approximately $30 on pamphlet creation and distribution (paper, ink, lamination) per 10
pamphlets. If the microsystem decides to continue the intervention beyond July 1, the hospital
will adopt the cost of the pamphlet distribution.
Description of the Intervention
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To improve oral care completion and knowledge among chemotherapy patients, an oral
care patient education session was implemented. The education session consisted of both verbal
and written education. The education material was based on evidence-based information from
the following sources: 1) The unit’s BMT oral care policy and 2) The MASCC/ISOO Clinical
Practice Guidelines and the associated oral care education pamphlet. Interventions aimed at
improving health literacy were utilized to promote optimal comprehension. First, the verbal
education was provided at a moderate pace, in nonmedical language. Second, the pamphlet was
written at a sixth-grade reading level with short, simple sentences. Research shows that use of
both verbal and written information increases patient knowledge and satisfaction (Johnson et al.,
2003). Third, the teach-back method was used to gauge comprehension. Lastly, all participants
were asked What questions do you have? to promote self-management and empowerment (Hersh
et al., 2015).
Starting on May 23, 2022, the project leader attended morning huddle and identified
chemotherapy patients on the unit. Eligible patients were provided with an informed consent and
interested participants first completed a pre-intervention survey, created by the project leader,
assessing their current oral care habits with the questions I brush my teeth twice a day while in
the hospital and I use an oral rinse after each meal and before bed while in the hospital. Patients
assigned themselves a score for each question based on the following Likert 5 Point Scale:
Never, Rarely, Sometimes, Often, Always. The survey also assessed patient baseline knowledge
with the questions I understand what OM is and I understand how oral care can impact my
health. Participants assigned themselves a score for each question based on the following Likert
5 Point Scale: Strongly Disagree, Disagree, Undecided, Agree, Strongly Agree. After completing
the pre-intervention survey, the project leader provided participants with an Oral Care for
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Chemo Patients educational pamphlet which was created by the project leader and previously
approved by the unit manager. The project leader verbally explained the information on the
pamphlet and used the teach-back method to confirm patient comprehension. The education
session was divided into five sections: 1) Patients were educated on OM and why chemotherapy
patients are at increased risk for developing OM, 2) Patients were educated on how oral care can
help prevent OM, 3) Patients were educated on the importance of toothbrushing, they were
coached to brush for 90 seconds each time with a soft-bristled toothbrush, 4) Patients were
educated on the importance of utilizing oral rinses (bland saline or medicated as prescribed by
their provider) after each meal and before bed, and 5) Patients were encouraged to use the oral
checklist on the pamphlet to physically check off when they complete each oral care intervention
throughout the day (Dartmouth-Hitchcock, 2022; International Society of Oral Oncology, 2016).
The pamphlet was left in a visible and easily accessible location on the patient’s bedside table.
The project leader carried out the intervention, however stakeholder involvement with the
unit manager, CNL, charge nurse, and staff nurses were vital to the success of the project. The
unit manager and the CNL were involved in the planning and approved the pre and postintervention survey as well as the patient education materials and content. The project leader
collaborated with the charge nurse at the start of the shift to identify the chemotherapy patients
on the unit. The project leader then communicated with the staff nurses to ensure the intervention
was not disrupting the nurse or patient.
Study of the Intervention
The participants were surveyed before and after the intervention to assess the impact of
the patient education session on oral care completion and knowledge. The post-intervention
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survey was completed at least 24 hours after the education session to examine the efficacy of the
intervention.
Measures
A survey was created to assess oral care completion and knowledge. This survey was
developed to measure the outcomes of the intervention because there was no current tool
specifically assessing oral care completion and knowledge. The final survey was approved by the
unit manager and CNL. No psychometric testing was performed on the tool, however the CNL
and unit manager, subject matter experts, validated the content of the survey. A Likert 5 Point
Scale was used to quantify responses with Never representing 1 point, Rarely representing 2
points, Sometimes representing 3 points, Often representing 4 points, and Always representing 5
points for the oral care completion data. Similarly, a Likert 5 Point Scale was also used to
quantify oral care knowledge data with Strongly Disagree representing 1 point, Disagree
representing 2 points, Undecided representing 3 points, Agree representing 4 points, and Strongly
Agree representing 5 points. The mean Likert scores and a paired t-test were used to compare the
pre and post-intervention scores. The mean score of the following two questions were used to
assess oral care completion: I brush my teeth twice daily while in the hospital and I use an oral
rinse after each meal and before bed while in the hospital. The mean score of the following two
questions assessed oral care knowledge: I understand what oral mucositis is and I understand the
impact oral care can have on my health. Demographic data such as age, gender, and type of
cancer was also collected as these factors contribute to incidence and severity of OM.
The specific outcome measures were to improve both oral care completion and oral care
knowledge by 20% after the implementation of the patient education intervention, by July 1,
2022. The global outcome measure was to decrease the incidence of chemotherapy-induced OM.
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Analysis
Oral care completion and knowledge were quantitatively evaluated by comparing pre and
post-intervention mean Likert scale scores. A paired t-test was used to determine if the mean
differences were significantly different. Standard deviation, frequency, and percentage were also
examined in the descriptive analysis. The scores of 10 adult chemotherapy patients were assessed
and provided insight into whether the oral care patient education session was effective. This
quantitative comparison assessed if the patient education intervention improved daily oral care
completion and knowledge.
Ethical Considerations
This proposal was submitted to the University of New Hampshire Department of Nursing
Quality Review Committee and received determination as a QI project exempt from Institutional
Review Board (IRB) approval. The intervention has been approved by the unit manager and
CNL. There was an element of convenience bias as not all chemotherapy patients in the
microsystem were be involved in the project which limits the generalizability of the findings.
Each participant received an informed consent stating that there was be no direct benefit to them
for their participation and that they could decline to participate at any time. No personal patient
information was collected. No additional risk was introduced to the participants. No conflicts of
interest were identified as the project leader completed this as a part of the University of New
Hampshire Direct Entry Master of Nursing capstone project and was not employed by the
facility.
Results
Results
Initial Steps of Intervention
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Between April 21, 2022 and May 7, 2022, the project leader created an informed consent
and an initial survey to assess pre-intervention and post-intervention data regarding oral care
completion and knowledge among chemotherapy patients. Oral care completion was assessed by
the following two statements: I brush my teeth at least twice daily while in the hospital and I use
an oral rinse after each meal and before bed while in the hospital. Oral care knowledge was
assessed by the following two statements: I understand what OM is and I understand how oral
care can impact my health. The survey questions utilized a Likert 5 Point Scale for scoring.
Adjustments were made to the survey to include demographic data including participant age,
gender, and type of cancer as those factors impact incidence and severity of OM (Treister, 2017).
Additionally, the pre-intervention survey was expanded to include the statement, I have received
previous education from my healthcare team about the importance of oral care, to further assess
the current state of oral care education within the microsystem. The post-intervention survey was
expanded to include the statements, I will continue to use the oral care educational pamphlet &
checklist provided to me and What did you find most helpful about this education session? The
project leader also created an oral care/OM educational pamphlet to distribute to patients during
the education session of the intervention. The informed consent, the pre and post-intervention
surveys, and the educational pamphlet were approved by key stakeholders in the microsystem as
well as the University of New Hampshire Nursing Department Quality Review Committee as
IRB exempt indicative of QI. The project leader printed the aforementioned materials, had the
educational pamphlets laminated prior to the intervention, and communicated with the
microsystem leadership to schedule the implementation of the intervention.
On June 22, 2022, the project leader attended morning huddle and collaborated with the
staff nurses to identify eligible chemotherapy patients in the microsystem. The project leader
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introduced herself to each eligible patient and reviewed the informed consent. Patients were
provided with the pre-intervention survey and the project leader left the room while the patients
completed the survey. The project leader collected the completed surveys and stored them in a
sealed envelope, identified only by room number so the correct post-intervention survey could be
distributed the following day. The project leader distributed the oral care educational pamphlet
and discussed the following five points: 1) What OM is and why chemotherapy patients are at
increased risk for developing it, 2) How oral care can help prevent OM, 3) The importance of
toothbrushing and proper technique including brushing for 90 seconds with a soft-bristled
toothbrush, 4) The importance of utilizing oral rinses (bland saline or medicated) after each meal
and before bed, and 5) The benefits of using the checklist on the pamphlet to physically check
off when each oral care activity was completed throughout the day. All participants were asked
What questions do you have? before concluding the session.
On June 23, 2022, the project leader followed up with the six participants at least 24
hours after the initial intervention. Each patient was provided with the post-intervention survey
and again the project leader left the room as the participants completed the survey. The
envelopes labeled with participant room numbers were shredded to preserve anonymity.
Completed post-intervention surveys were collected and patients were thanked for their time.
Details of the Process Measures and Outcomes
The number of participants involved in the QI project was N=6. 66.7% of participants
identified as female and 33.3% identified as male. The mean age of the participants was 65.7
years old (SD = 6.8, range = 54-74). 100% of participants had a hematological malignancy,
16.7% with multiple myeloma, 33.3% with a form of lymphoma (primary central nervous system
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lymphoma and B-cell lymphoma), and 50% with various forms of leukemia (acute myeloid
leukemia, acute lymphocytic leukemia, and plasma cell leukemia).
Table 1
Demographic Data
Demographic Data

Total Sample (N=6) n (%)

Gender
Female
Male

4 (66.7)
2 (33.3)

Age
54
64
65
67
70
74

1 (16.7)
1 (16.7)
1 (16.7)
1 (16.7)
1 (16.7)
1 (16.7)

Cancer Diagnosis
Multiple Myeloma
Acute Lymphocytic Leukemia
Acute Myeloid Leukemia
Plasma Cell Leukemia
Primary CNS Lymphoma
B- Cell Lymphoma

1 (16.7)
1 (16.7)
1 (16.7)
1 (16.7)
1 (16.7)
1 (16.7)

Figure 1
Gender Distribution Among Participants
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Figure 2
Cancer Diagnoses Among Participants

Table 2
Descriptive Statistics for Key Study Variables
Variable

I brush my
teeth at least
twice daily
while in the
hospital
I use an oral
rinse after
each meal
and before
bed while in
the hospital
I understand
what oral
mucositis
(OM)
I understand
how oral care
can impact
my health

PreIntervention
M
3.3

PreIntervention
SD
1.6

PostIntervention
M
4.7

PostIntervention
SD
0.5

Range

1-5

3.2

1.6

3.8

1.2

1-5

3.3

1.4

4.7

0.5

1-5

4.2

1.6

4.8

0.4

1-5
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The means and standard deviations (SD) were calculated for the pre and post-intervention
scores for each survey question. Paired t-tests were conducted to calculate p values to determine
if there was a statistically significant difference between the pre and post-intervention scores. All
statistical analysis was conducted with Google Sheets™. Participants could indicate Never,
Rarely, Sometimes, Often, Always for their oral care completion habits, which were respectively
assigned scores of 1 through 5. The mean pre-intervention score in response to the statement, I
brush my teeth at least twice daily while in the hospital, was 3.3 (SD = 1.6, range 1-5), the mean
post-intervention score was 4.7 (SD = 0.5, range 1-5) (p = 0.043). The mean pre-intervention
score in response to the statement, I use an oral rinse after each meal and before bed while in the
hospital, was 3.2 (SD = 1.6, range 1-5), the mean post-intervention score was 3.8 (SD = 1.2,
range 1-5) (p = 0.102).
Figure 3
Mean Oral Care Completion Likert Scale Scores
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Participants could indicate Strongly Disagree, Disagree, Undecided, Agree, Strongly
Agree for their oral care knowledge, which were respectively assigned scores of 1 through 5. The
mean pre-intervention score in response to the statement, I understand what OM is, was 3.3 (SD
= 1.4, range 1-5), the mean post-intervention score was 4.7 (SD = 0.5, range 1-5) (p = 0.025).
The mean pre-intervention score in response to the statement, I understand how oral care can
impact my health, was 4.2 (SD = 1.6, range 1-5), the mean post-intervention score was 4.8 (SD =
0.4, range 1-5) (p = 0.235).
Figure 4
Mean Oral Care Knowledge Likert Scale Scores

The mean score in response to the statement, I have received previous education from my
healthcare team about the importance of oral care, was 3.3 (SD = 1.6, range 1-5). The mean
score in response to the statement, I will continue to use the oral care educational pamphlet &
checklist provided to me, was 4.2 (SD = 0.8, range 1-5).
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In response to the question, What did you find most helpful about this education session?,
66.7% of participants wrote that the education session was a useful reminder about the
importance of oral care. Specific answers included, Reminders about oral health are always
welcome, reminders about brushing and rinsing, the importance of cleaning, and the checklist to
remind me every day. 33.3% of participants did not answer this question.
Contextual Elements that Interacted with the Intervention
This author is grateful for the support of the microsystem leadership (unit manager and
CNL); the resources they provided to the project leader and their timely feedback on project
ideas and materials were instrumental to the success of this project. The project leader required
microsystem specific data and resources to complete this QI work and there were at times
competing priorities such as COVID-19 and staffing shortages. Despite these challenges, the unit
manager and CNL prioritized communicating with and assisting the project leader with the
development of this project. As previously discussed, the mission statements of the macro, meso,
and microsystems reflect a commitment to quality improvement as all levels of care strive to
provide high-quality care and improve patient outcomes and experiences. The unit manager and
CNL’s behavior reflects this and their commitment to QI is admirable.
Observed Associations Between Outcomes, Interventions, and Relevant Elements
All post-intervention survey responses were higher than the pre-intervention survey
responses. However, only the statement I brush my teeth at least twice daily while in the hospital
had a statistically significant improvement for oral care completion (p = 0.043) and the statement
I understand what oral mucositis is had a statistically significant improvement for oral care
knowledge (p = 0.025). Additionally, all participants completed both the pre and post-
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intervention surveys, however 33.3% of participants declined to answer the question, What did
you find most helpful about this education session? on the post-intervention survey.
Unintended Consequences
The project leader was the only individual carrying out this intervention, however staff
nurses on the floor expressed interest in using the educational pamphlets for their future
chemotherapy patients. One staff nurse stated that The pamphlets are a great reminder for
patients, another stated, I’d love to put the pamphlets in with our other patient resources for
future use. These statements reflect an intention to continue using the pamphlets and to have oral
care patient education become a standard of care for chemotherapy patients.
The project leader estimated spending $20 per 10 surveys/educational pamphlets,
however actually spent $34.50 on required resources for this project. The project leader utilized
the public library for printing where the pamphlets cost $1 per colored page (total of $10) and
$0.15 per black/white page for the informed consent/surveys (total of $4.50). The project leader
had the pamphlets laminated at Staples for $1.99 per page (total of $19.90). While the cost of
$34.50 is nominal when compared with the $70,000 that OM complications and care can accrue,
it is important for nurse leaders to have a strong understanding of the costs of their work.
Details about Missing Data
The project leader initially planned to include 10 participants in the QI project so the
number of participants, N=6, was smaller than anticipated. On June 22, 2022, eight
chemotherapy patients were admitted to the microsystem and eligible for participation, however
one patient declined to participate and one patient was off the unit for the day resulting in six
patients participating in the intervention. Furthermore, 33.3% of participants declined to answer
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the question, What did you find most helpful about this education session?, where patients were
encouraged to free type their answers.
Discussion
Summary
Key Findings
The global aim of this project was to reduce incidence of chemotherapy-induced OM
among chemotherapy patients. The specific aims of this project were to improve both oral care
completion and knowledge by 20% by July 1, 2022. Oral care completion was measured by the
survey statements I brush my teeth at least twice daily while in the hospital and I use an oral
rinse after each meal and before bed while in the hospital. Oral care knowledge was measured
by the survey statements I understand what OM is and I understand how oral care can impact
my health. The specific aims were only partially achieved. For example, oral care completion
improved by 28% for toothbrushing but only by 12% for oral rinsing. Additionally, oral care
knowledge improved by 28% for OM understanding but only by 12% for understanding the
impact of oral care on one’s health. While these improvements did not fully achieve the specific
aims, the improvement seen across all survey statements demonstrated the importance and
effectiveness of the intervention.
Strengths of the Project
One strength of this QI project was the high participation rate of chemotherapy patients.
75% of eight eligible patients participated, one patient declined and one patient was off the unit
for a procedure. Despite the small number of participants, the high participation improves the
generalizability of the findings. Another strength, as previously discussed in the results section,
was the support of the unit manager and CNL. Their willingness to provide support allowed the
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project leader to carry out the QI project with minimal disruptions and will contribute to the
longevity of the intervention after the project has concluded.
Interpretation
Association Between Intervention and Outcome
When interpreting the outcomes of the oral care educational intervention, the quantitative
and qualitative data support the association between the intervention and improved oral care
completion and knowledge. There was a 28% increase in toothbrushing (p = 0.043), a 12%
increase in oral rinsing (p = 0.102), a 28% increase in understanding of OM (p = 0.025), and a
12% increase in the understanding of the impact of oral care on one’s health (p = 0.235). The
statistically significant improvements seen in the toothbrushing (p = 0.043) and understanding of
OM (p = 0.025) highlight the impact the intervention had on improving oral care habits of
chemotherapy patients within the microsystem. While oral rinsing (p = 0.102) and understanding
of the impact of oral care on one’s health (p = 0.235) were not statistically significant, the 12%
increase in post-intervention scores still represents improved oral care habits. Collectively, these
improvements reflect the effectiveness of the intervention and address the specific aims of
improving oral care completion and knowledge.
Comparison of Results
The literature supports these findings, with the most recent MASOO/ISOO Clinical
Practice Guidelines stating that oral care patient education improves self-management and
adherence to oral care protocols (Hong et al., 2019). Similarly, the work of Rapone et al. (2016)
suggests that patient education is central to changing oral care habits. They found that patient
education improves patient motivation to complete oral care, and in turn reduces incidence and
severity of OM (Rapone et al., 2016). Research shows that use of both verbal and written
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information increases patient knowledge and satisfaction (Johnson et al., 2003). This intervention
coupled a written educational pamphlet with verbal education to optimize patient
comprehension, resulting in post-intervention improvements across all survey statements.
Influence of Context
While the intervention was associated with improved oral care and knowledge, the
specific aims were not fully met. Participants’ lack of access to oral rinse supplies may have
contributed to the less than 20% improvement in oral completion. Additionally, high preintervention scores for the statement I understand how oral care can impact my health
contributed to the less than 20% improvement in post-intervention scores. With a preintervention mean score of 4.2 (SD = 1.6, range 1-5), an optimal mean post-intervention score of
5 would still be less than the anticipated 20% increase.
Project Impact
Despite the variance from anticipated outcomes, the overall response to the project from
patients and staff was positive. Participants expressed that the intervention was informative and
was a great reminder to complete regular oral care in the hospital. Staff expressed interest in the
intervention and verbalized wanting to sustain the intervention after the conclusion of the project.
Overall, this project improved patients oral care completion and knowledge which can result in
positive patient experiences and outcomes.
Cost Benefit Analysis
The total cost of this QI project was $34.50. The project leader covered the expenses for
this project, however the hospital would incur these costs going forward. OM complications and
care can contribute to costs upward of $70,000 in chemotherapy and BMT patients so this
intervention proved to be cost efficient (Elting & Chang, 2019).
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Limitations
One limitation to this project was the comparability at baseline of the participants’ ages
and cancer diagnoses. All participating patients were between 54 and 74 years old and had a
hematological malignancy (multiple myeloma, leukemia, and lymphoma), this limits the
generalizability of the findings to patients in this age range and with a hematological oncological
diagnosis. The results cannot be inferred to patients of different ages and with non-hematological
cancer diagnoses. Additionally, the small number of participants, N=6, limits the generalizability
as the results can only be applied to this small, specific population.
Internal validity of the project was further limited by imprecision in the project design
where the post-intervention follow up was only conducted 24-30 hours after the initial
intervention. The proximity of the intervention and post-intervention data collection hinders
conclusions that can be drawn about true behavior change.
In order to limit convenience bias, all patients eligible for this project, those with an
oncology diagnosis, undergoing chemotherapy, were asked to participate. One patient was off
the unit and one patient declined, however attempting to include all eligible participants allows
the results to be generalizable to the oncology/chemotherapy patient population within the
microsystem at this time.
Conclusions
While this project was specific to the oncology/chemotherapy patient population, an oral
care education intervention can be applied to other contexts. Oral health and overall health are
closely connected and research shows that oral health can be linked to numerous conditions
including endocarditis, cardiovascular disease, and pneumonia, highlighting a need for oral care
interventions across all critical care and medical-surgical units in acute care settings (Mayo
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Foundation, 2022). The positive impact that oral care can have on the health outcomes of
chemotherapy patients as well as other vulnerable patient populations highlights the usefulness
and the importance of the intervention.
The sustainability of the project was limited by the project leader being the only one to
carry out the intervention. Key stakeholders were involved in the planning and approval of the
project, however staff participation in the implementation of the project likely would contribute
to greater longevity of the intervention within the microsystem. The ultimate goal of a QI project
is to create true behavior change and staff buy-in is central to creating a new, evidence-based
status quo.
In this project, the post-intervention survey was conducted 24 to 30 hours after the initial
intervention. Future projects may want to consider weekly follow ups with the participants which
may result in a more thorough understanding of the oral care completion habits and knowledge
of the chemotherapy patients and would better evaluate the efficacy of the intervention.
Additionally, the microsystem may want to update their oral care policy to reflect all
chemotherapy patients on the unit, rather than just BMT patients. In conclusion, this QI project
highlighted numerous CNL roles and competencies including the role of the CNL as an educator,
client advocate, and lifelong learner. Quality improvement and the role of the CNL as a nurse
leader and innovator is central to improving health outcomes and providing person-centered and
evidence-based care to patients.
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